Observational studyOrphanet journal of rare diseases2025

A multi-country time and motion study to describe the experience and burden associated with the treatment of Fabry disease with enzyme replacement therapy with agalsidase alfa and agalsidase beta.

Ian Keyzor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.